Literature DB >> 6651872

Free radical metabolism of VP-16 and inhibition of anthracycline-induced lipid peroxidation.

B K Sinha, M A Trush, B Kalyanaraman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6651872     DOI： 10.1016/0006-2952(83)90385-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  5 in total

1.  Effect of etoposide (VP16-213) on lipid peroxidation and antioxidant status in a high-dose radiochemotherapy regimen.

Authors:  C Ladner; G Ehninger; K F Gey; M R Clemens
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 2.  The clinical pharmacology of etoposide and teniposide.

Authors:  P I Clark; M L Slevin
Journal:  Clin Pharmacokinet       Date:  1987-04       Impact factor: 6.447

3.  Influence of polysorbate 80 (Tween 80) and etoposide (VP-16-213) on the pharmacokinetics and urinary excretion of adriamycin and its metabolites in cancer patients.

Authors:  J Cummings; G J Forrest; D Cunningham; N L Gilchrist; M Soukop
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 4.  A chemical perspective on the anthracycline antitumor antibiotics.

Authors:  B R Abdella; J Fisher
Journal:  Environ Health Perspect       Date:  1985-12       Impact factor: 9.031

5.  Modulation of therapy-induced senescence by reactive lipid aldehydes.

Authors:  A C Flor; A P Doshi; S J Kron
Journal:  Cell Death Discov       Date:  2016-07-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.